Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedAn Open-label, Randomized, Parallel Arm, Bioavailability Trial of Aripiprazole IM Depot Administered in the Deltoid or Gluteal Muscle in Adult Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Cerritos
Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia
This study has finished and is no longer accepting participants.
In ChibaResearchers studied Allopurinal to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedAn Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
This study has finished and is no longer accepting participants.
In New HavenAn Open-label Study Evaluating the Maintenance of Clinical Effect in Adults With Schizophrenia Switched From RISPERDAL® Tablets (Risperidone) to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study assessed thinking abilities.
This study has finished and is no longer accepting participants.
In AugustaAn Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BellevueA 12-week , Randomized, Phase 2, Double-blind, Parallel-group Study Of Two Dose Levels Of Pf-02545920 Compared To Placebo In The Adjunctive Treatment Of Outpatients With Sub-optimally Controlled Symptoms Of Schizophrenia
This study ended early.
Multiple locations, including BirminghamCitalopram Augmentation in Older Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoThis study has finished and is no longer accepting participants.
In TorontoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.